In 2014, Keryx Biopharmaceuticals needed to quickly build a commercial
foundation for product sales and marketing to support its first
FDA-approved product, Auryxia™ (ferric citrate). Keryx required a
best-of-breed solution that would enable business agility and continuous
improvement, plus easily accommodate change and rapid growth.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.